Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Research waste among randomized clinical trials in endoscopic resection of gastrointestinal lesions: a cross-sectional study of ClinicalTrials.gov.

BMC gastroenterology·2025
Same author

Impaired pericyte-Müller glia interaction <i>via</i> PDGFRβ suppression aggravates photoreceptor loss in a rodent model of light-induced retinal injury.

International journal of ophthalmology·2024
Same author

Positioning exercises in improving the quality of magnetic-controlled capsule endoscopy.

BMC gastroenterology·2024
Same author

[Effect of Optimized Fertilization and Biochar Application on Phosphorus Loss in Purple Soil Sloping Farmland].

Huan jing ke xue= Huanjing kexue·2020
Same author

Experimental circumferential canaloplasty with a new Schlemm canal microcatheter.

International journal of ophthalmology·2018
Same author

Infliximab relieves blood retinal barrier breakdown through the p38 MAPK pathway in a diabetic rat model.

International journal of ophthalmology·2017
Same journal

Artificial intelligence for diagnosis of keratoconus using Scheimpflug based corneal tomography.

International journal of ophthalmology·2026
Same journal

Falling short of the target: effective cataract surgical coverage and the road to 2030.

International journal of ophthalmology·2026
Same journal

Multimodal imaging features of optic disc melanocytoma in a Chinese population.

International journal of ophthalmology·2026
Same journal

Comparison of posterior scleral reinforcement surgery and repeated low-level red-light therapy in controlling high and super high myopia in Chinese children.

International journal of ophthalmology·2026
Same journal

CORRIGENDUM.

International journal of ophthalmology·2026
Same journal

Curcumin protects the diabetic mouse retina by modulating the Hippo-YAP signaling pathway.

International journal of ophthalmology·2026
See all related articles

Related Experiment Video

Updated: May 22, 2026

Sub-Retinal Delivery of Human Embryonic Stem Cell Derived Photoreceptor Progenitors in rd10 Mice
07:46

Sub-Retinal Delivery of Human Embryonic Stem Cell Derived Photoreceptor Progenitors in rd10 Mice

Published on: October 6, 2023

Mesenchymal stem cells for retinal diseases.

Wei Xu1, Guo-Xing Xu

  • 1Fujian Institute of Ophthalmology, the First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, Fujian Province, China.

International Journal of Ophthalmology
|May 4, 2012
PubMed
Summary
This summary is machine-generated.

Mesenchymal stem cells (MSCs) offer potential for treating retinal diseases by protecting cells from death. While direct retinal cell differentiation remains challenging, MSCs show promise for neuroprotection against vision loss.

Keywords:
differentiationmesenchymal stem cellsneurotrophinretina

More Related Videos

Efficient Derivation of Retinal Pigment Epithelium Cells from Stem Cells
07:07

Efficient Derivation of Retinal Pigment Epithelium Cells from Stem Cells

Published on: March 8, 2015

Isolation of Retinal Stem Cells from the Mouse Eye
07:22

Isolation of Retinal Stem Cells from the Mouse Eye

Published on: September 11, 2010

Related Experiment Videos

Last Updated: May 22, 2026

Sub-Retinal Delivery of Human Embryonic Stem Cell Derived Photoreceptor Progenitors in rd10 Mice
07:46

Sub-Retinal Delivery of Human Embryonic Stem Cell Derived Photoreceptor Progenitors in rd10 Mice

Published on: October 6, 2023

Efficient Derivation of Retinal Pigment Epithelium Cells from Stem Cells
07:07

Efficient Derivation of Retinal Pigment Epithelium Cells from Stem Cells

Published on: March 8, 2015

Isolation of Retinal Stem Cells from the Mouse Eye
07:22

Isolation of Retinal Stem Cells from the Mouse Eye

Published on: September 11, 2010

Area of Science:

  • Ophthalmology
  • Regenerative Medicine
  • Cell Biology

Background:

  • Retinal diseases often lead to irreversible vision loss due to retinal cell apoptosis.
  • Current therapeutic strategies for retinal cell death have limited effectiveness.
  • Mesenchymal stem cells (MSCs) are multipotent cells with self-renewal properties, showing promise in regenerative medicine.

Purpose of the Study:

  • To explore the potential of mesenchymal stem cells (MSCs) in addressing retinal cell apoptosis and vision loss.
  • To evaluate MSCs as a source for cell replacement or neuroprotection in retinal disorders.
  • To investigate the feasibility of using MSCs for neuroprotection given challenges in their differentiation into functional retinal cells.

Main Methods:

  • Reviewing existing research on MSCs and their application in retinal disorders.
  • Analyzing the potential of MSCs to differentiate into retinal cells under specific stimuli.
  • Examining the neuroprotective capabilities of MSCs through the secretion of neurotrophins.
  • Assessing the use of engineered MSCs for sustained neurotrophin delivery.

Main Results:

  • MSCs can be induced to express retinal cell markers, though functional differentiation remains a barrier.
  • MSCs secrete various neurotrophins, suggesting a strong potential for neuroprotection.
  • Engineered MSCs have demonstrated encouraging results in delivering neurotrophins to combat retinal degeneration.

Conclusions:

  • Mesenchymal stem cells (MSCs) represent a promising therapeutic avenue for retinal diseases.
  • Neuroprotection via MSCs is a more practicable approach than direct cell replacement due to differentiation challenges.
  • Further investigation into MSC-based neuroprotection is warranted for treating retinal degeneration and preventing vision loss.